PreprintAll rights reservedbioRxiv
Engineering human myelin microphysiological systems for testing patient treatment response in multiple sclerosis
- 1Indiana University Bloomington
Related
- A two year clinical, immunological and gut-brain-axis prospective study to predict treatment response to cladribine tablets in relapsing-remitting multiple sclerosis
- Viral immune profiles in multiple sclerosis and HIV co-infection providing insights into antiretroviral treatment-associated immuno-remodeling
- Multiple Sclerosis Patient Macrophages Impaired Metabolism Leads to an Altered Response to Activation Stimuli
- Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.
- Pathophysiology and imaging of early memory impairment in multiple sclerosis
BibTeX
@misc{tian2026engineering,
title = {{Engineering human myelin microphysiological systems for testing patient treatment response in multiple sclerosis}},
author = {C. Tian and Z. Ao and H. Cai and J. Wang and N. Wang and J. Tchieu and H.-C. Lu and K. Mackie and M. Gu and F. Guo},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.12.750449},
url = {https://www.biorxiv.org/content/10.64898/2026.09.12.750449v1},
}
RIS
TY - UNPB
TI - Engineering human myelin microphysiological systems for testing patient treatment response in multiple sclerosis
AU - C. Tian
AU - Z. Ao
AU - H. Cai
AU - J. Wang
AU - N. Wang
AU - J. Tchieu
AU - H.-C. Lu
AU - K. Mackie
AU - M. Gu
AU - F. Guo
PY - 2026
DA - 2026/09/12
PB - bioRxiv
DO - 10.64898/2026.09.12.750449
UR - https://www.biorxiv.org/content/10.64898/2026.09.12.750449v1
ER -